↩ Go Back
Need help?

Healthcare Business Investment Opportunities

Showing 1 - 15 of 846 Healthcare Business Investment Opportunities. Invest in a Healthcare, Pharmacy, Beauty and Wellness, Advanced Medical Technology, Medical Supply and Equipment, Healthcare Service, Pharmaceutical or a Biotechnology Business.

Filters
  • Healthcare

  • Investment Opportunities

 

Bio Therapeutic Drugs Business Investment Opportunity in Manlius, United States

Company developing diagnostics & therapeutics for skin cancer: basal cell carcinoma, squamous cell carcinoma, melanoma.
- The company currently works with pharmaceutical and diagnostic companies, research institutes, CROs, and CDMOs to help them develop molecular bioassays and digital pathology products, and to visualize and analyze the resultant data via AI and ML for the benefit of patients, their family, and their healthcare providers. - Currently, has 3 clients: Klotho Therapeutics Inc. (a biotechnology company in San Diego, CA, USA), Unger Medical PC (a hair restoration medical practice in NY, NY, USA), and Astrix Technology Group (a life sciences strategy, technology, and staffing services company based in Red Bank, NJ, USA). • Target Market: - The business is specialized in developing diagnostics and therapeutics for human basal cell carcinoma, squamous cell carcinoma, and melanoma. This skin cancer group comprises the most diagnosed cancers worldwide of all cancer types with over five million cases diagnosed each year. - The skin cancer therapeutics diagnostics and therapeutics products industry worldwide were worth $8.2 billion USD in 2019 and is projected to reach $15 billion by 2027. This represents a CAGR of 7.5%. - What share of the total skin cancer target market can we estimate is realistic for to obtain? A conservative estimate is that our company should be able to reach $150 million USD in annual revenues by the close of 2028. • Problem or Need: - The main project involves the development of a Skin Cancer Patient Data Blockchain. - Currently there is a serious problem concerning how oncology patients organize and share their medical data, how companies get access to this data, and a lack of return in value to the patients for sharing their personal data. The blockchain is designed to tackle and solve these problems. - The blockchain for skin cancer patients will be comprised of multiple decentralized nodes contributing data to a shared ledger where patients can set up smart contracts to share and control their data. - Skin cancer patients will be able to share their data with research institutions, drug companies, diagnostic companies, contract research organizations, client trials organizers, and other stakeholders. - Also, planning to launch a medium of exchange within the blockchain system to allow patients to be given money for participation in the sharing of their data with the mentioned company stakeholders. - Therefore, the company stakeholders that plan to utilize the patient’s data would provide revenues and income to support the operations of the blockchain. - For example, pharmaceutical companies would be important customers that the business would cultivate as users of the patient’s healthcare data. This is because pharma companies can use this blockchain to discover patients with the right profile for a skin cancer clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. This should greatly streamline for the pharma company the time it takes to enroll the right patients into clinical trials and get them started. • Solution: - What is the core value proposition? For the company stakeholders in the skin cancer patient blockchain, the business is hoping to demonstrate that this blockchain technology will be a way to improve business outcomes through better efficiency, risk management, and security. - For these customers, this will enable them to maintain and capture new sources of profit. At the same time, company stakeholder participation will also grow the business as the integrator and host of the blockchain and result in significant profit growth for the company. • Team: The team is comprised of: - Founder, President, and CEO, a 100% full-time permanent employee has a Ph. D. in Cell and Molecular Biology from St. John’s University (New York, NY), a M. S. in Microbiology & Immunology from Long Island University, and a M. B. A. from Le Moyne College. In addition, he has 20 years of quality assurance and regulatory affairs experience at the Bristol-Myers Squibb Company, Charles Rivers Laboratories, and Vybion, Inc. This includes moving numerous human therapeutic products from R&D, through clinical trials, and into the marketplace via approval by the US FDA and worldwide regulatory bodies. In addition to the above experience, and an addition 18 year of experience in human therapeutics research and development and in the management of laboratory-based cell culture, toxicological, or bioassay projects within the biopharmaceuticals industry. However, he is a Senior Member of the food, drugs & cosmetics section of the American Society for Quality (ASQ), and a society member of The American Association for the Advancement of Science (AAAS). - The President of Hillberg Consulting is a part-time, non-permanent hourly contract employee of R&D department. She is an accomplished executive and board member with a reputation for delivering bottom-line profitability while building the infrastructure to support growth and success. She has served at Johnson & Johnson Ortho Clinical Diagnostics as VP of R&D, and as Chief Technology, Officer at Carestream Health. Holly has a B. S. in Chemical Engineering from Michigan Technology University and a M. S. in Electrical Engineering from Rochester Institute of Technology. - Marketing Consultant - part-time, non-permanent hourly employee. He is a professional engineer and entrepreneurial executive with focus on emerging technology solutions applied to real world problems. He has substantial experience in team building and in developing market strategies & partnerships. This includes over two decades of technology & networks business planning, development, & implementation. He has a Masters in Entrepreneurial Studies - MIT Sloan School of Management, and M. S. & B. S. in Engineering from Syracuse U. and Utica College. - Blockchain Development Technical Project Management Consultant - Part-time, non-permanent hourly employee that is a contractor from EffectiveSoft Corporation, San Diego, CA. She has eight years of experience as VP of Service Delivery and as the Head of Sales for enterprise level software solutions at Effective Soft Corp. She has a M. B. A. from The University of Manchester and a B. S. degree from Minsk State Linguistics U. – Legal Counsel - Part-time, non-permanent hourly contract employee. He holds the Juris Doctor from Boston College Law School, and B. A. in Political Science from Binghamton University. He is a Partner at Newman & Lickstein, with eight years of experience in representing technology companies and investors in licensing, IP development, real estate, mergers & acquisitions, and business litigation. - Demonstrating results to stakeholders will be the key to success. For skin cancer, there is a lot of data collected from various heterogeneous sources – pathology imaging data, genetic testing, surgery, drugs intervention, payer, and insurance information, etc. - Some companies are using a website or app to meet the social needs of patients to discuss their concerns with other patients or a few qualified physicians. No competitor is comprehensively focusing on skin cancer data & treatment to the level that we do. Possible competitors have thus not yet integrated the patient data, shared consent, and the patient monetization blocks together into a comprehensive and workable blockchain system for skin cancer patients, or for any segment of the oncology market, for that matter. - This team, on the other hand, has decades of experience in oncology research, the development of products and services for cancer patients, in oncology clinical biomedicine and in oncology marketing, and that makes the company well-equipped to solve the problems around skin cancer patient data acquisition, its organization, and its beneficial use for the patients and for their healthcare providers. For example, regarding the latter, the company also harnesses artificial intelligence (AI) and machine learning (ML) to extract relevant data from the patient’s database that will help healthcare providers to better understand the patient’s tumor and the tumor microenvironment (i. e. , tumor growth, cellular migration, blood supply to the tumor, subcellular trafficking, and tumor metastasis), drug efficacy (including drug penetration into the tumor, possible tumor shrinkage or tumor death, and drug toxicity, and side effects), or the immediate or long term results of surgical intervention. - When competitors enter this specific market, the business plans to stand out by utilizing a value-based strategy that clearly displays our brand and the above competitive advantage. • Traction: - Currently works with pharmaceutical and diagnostic companies, research institutes, and contract research development and manufacturing companies to help them obtain and organize their molecular bioassays and pathology data. We propose to utilize this traction and intercompany personal connections to gain and grow customers that will use and pay for patient data on the blockchain. - Also use social media & patient advocacy organization to recommend the blockchain to skin cancer patients so that we can grow the patient database. - The company is also a member of the Hyperledger Foundation Healthcare Special Interest Group. Hyperledger, as part of the Linux Foundation, provides technology leaders a uniquely open and collaborative international community from which to develop, validate, and field enterprise-grade blockchain technology solutions. It is the mandate of the Hyperledger Healthcare Special Interest Group (HC-SIG) to represent healthcare professionals and technologists, to globally unite these individuals, and to advance the state of the healthcare industry through the implementation of technology solutions using blockchain technologies in general, and the umbrella of Hyperledger frameworks and toolsets specifically. • Revenue Model: - Within the ecosystem surrounding the above patients, who would buy/lease the skin cancer blockchain services that the company wish to market? In this blockchain system, individuals will be allowed to store and monetize their own health data including blood test results, medical history, genetic profile, skin photographs, pathology images and other sensitive information. - In the healthcare marketplace, cancer patients would be paid in stablecoin currency to lease their individual data to companies for a certain amount of time. - Pharmaceutical (pharma) companies would be important customers that the company would cultivate as users of the patient’s permitted healthcare data. - Blockchain can help pharma companies discover patients with the right profile for a clinical trial, even if those patients were not actively searching to participate in a clinical trial for a product from which the pharma or diagnostics company might benefit. - According to Milind Kamkolkar, chief data officer at Sanofi, patients could be prompted based on their data to join a clinical trial, thereby also accelerating the process and accuracy of trial recruitment. Using this blockchain if a person declines, no personal information will be shared, and the person's identity will remain private. If the person agrees, the overall process will move faster by abolishing the need for intermediaries. - For pharma companies, better inclusion in clinical trials and better reproducibility for studies can reduce the time and money needed to develop new drugs. - Besides pharma companies, research institutes will be willing to pay for the data from skin cancer patients, and the introduction of our blockchain-based data ecosystem may help ensure that the individuals take control over their data and companies and research institutions may acquire data more freely after the latter have obtained consent from individual patients. - How are the products and services going to generate revenue? The most straightforward way to generate revenue is to have the blockchain client customers pay for the products and services that exceeds by a large margin what it costs to develop and operate the blockchain (a cost-plus strategy). - When competitors enter this specific market, plan to stand out by utilizing a value-based strategy that clearly displays the brand and competitive advantage. • Market Projections: - What share of the total skin cancer blockchain target market can we estimate is realistic for to obtain? The global skin cancer blockchain customer market size stood at USD 8.19 billion in 2019 and is projected to reach USD 14.55 billion by 2027, exhibiting a CAGR of 7.5% during the forecast period. A conservative estimate is that the company should be able to reach $150 million in annual revenues in 4 years. - These financial projections would be possible because of the company participating and partnering with individuals and companies within the oncology community to create superior value for the products and services. - Over the next 4 years, the company anticipates receiving funding from investors, and revenues from pharmaceutical companies and research institute customers. - However, expenditures are also expected to increase. Expenses incurred will be for the development of products and services, and for personnel, equipment, supplies, business development & marketing. • Competition: - Have identified Nebula Genomics and Longenesis as competition. These two leading firms in artificial intelligence and blockchain technology for healthcare, are developing a platform for the storage and exchange of genomic data. - Nebula Genomics is a San Francisco-based biotechnical company that uses blockchain to “build a marketplace” for clinical genetics data. - Longenesis is a Hong Kong-based partnership between Insilico Medicine and the Bitfury Group, which makes blockchain platforms for the exchange of health data. - The above companies will reportedly apply artificial intelligence and blockchain technology to develop a platform for individuals and large data providers to store, manage, exchange, and profit from genomic and other types of clinical data. To automate data acquisition, the project developed by both Nebula Genomics and Longenesis will utilize smart contracts. - Unlike the Nebula Genomics and Longenesis blockchains, this blockchain project will be focused on oncology patients and the ecosystem around them rather than on a multitude of disease sectors. - In addition to Nebula Genomics and Longenesis, the U. S. -based life science research marketplace, Scientist. com, has revealed the development of a pharmaceuticals blockchain platform. This latter blockchain-powered platform is reportedly designed to track and protect pharmaceutical data. Thus, the Scientist. com DataSmart TM platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered before submission to regulators such as the FDA and the EMEA. - However, the above platforms do not adequately address the pressing concerns of cancer patients regarding the control and sharing of their personal data. Competitive Advantage: • Strategy. Specifically for oncology blockchain products, the major company players that may join our blockchain to gain access to data from skin cancer patients include: Almirall S. A. Amgen, Inc. Boehringer Ingelheim GmbH. Bristol-Myers Squibb Company. Eli Lilly and Company. Elekta AB. F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc. Merck & Co. , Inc. Mylan NV. Novartis AG. Pfizer. Regeneron. Sanofi. Sun Pharmaceutical Industries Ltd. Varian Medical Systems, Inc. Sensus Healthcare. ICAD, Inc. Accuray, Inc.
Company developing diagnostics & therapeutics for skin cancer: basal cell carcinoma, squamous cell carcinoma, melanoma.
9.5   Manlius
Run Rate Sales
USD 26 thousand
EBITDA Margin
35 %
Financial Investment
USD 1 Mn for 25%
Contact Business

Gym Investment Opportunity in Gurgaon, India

Modernizing neighborhood gyms in India with next-gen tech for an unmatched experience.
Business Highlights. Approach involves enabling the neighborhood budget or mid-tier gyms with the country's most advanced gym tech and eventually helping them achieve revenue growth month on month. - Offering India's first recurring subscription-based gym memberships at ₹599/$7 monthly. - Membership includes access to premium facilities, personalized nutrition plans, online fitness sessions, and AI assistance. - Achieved $72K monthly revenue and secured $300K in funding, aiming for $1 million to expand to 100 gyms. We are on track to reach USD 150 to 200k MRR in the next 90 days. - Received a term sheet for $250K and commitments from 4 unicorn founders for funding. - Pipeline of 46 new WTF Properties both Managed and Powered set to open in the next 4 months. - Supported by notable angels. - We have impacted 17,000 users, with 6,000 active members, pioneering India's smartest gym tech ecosystem.
9.0   Gurgaon
Run Rate Sales
USD 430 thousand
EBITDA Margin
Nil
Financial Investment
USD 430 K for 14%
Contact Business

Diagnostic Lab Investment Opportunity in Madurai, India

Non-operational prenatal screen lab that used to receive 10+ daily samples when operational seeking investment.
- We are a prenatal diagnostic lab that is currently non-operational. - We are the number 1 lab for prenatal services. - This diagnostic centre is FMF approved platform. - On average, we receive 10+ samples daily. - In the next 6 months, we plan to increase the number of samples to 200-300. - Promoter has 12+ years of experience. - The business has been non-operational for the last 2 months as the business is incorporating a new software that is the first of its kind in India. - Business has Udyam, BMW, and NABTCL certificates.
7.1   Madurai
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 12 K for 10%
Contact Business

Pharma Marketing Business Investment Opportunity in Bahraich, India

Pharma marketing company catering to 250 clients seeks investment.
1. Established firm: The company has a strong establishment, having been in the industry for 14 years, demonstrating stability and experience in the pharma marketing sector. 2. Wide client base: With over 250 clients, the company has a well-established customer base, indicating a strong market presence and potential for sustained revenue streams. 3. Niche Market Focus: The company specializes in marketing analgesic products to doctors and chemists, indicating a specific focus within the pharmaceutical marketing sector. 4. Growth Potential: With a relatively small team of 3 employees, there is potential for scalability and expansion, presenting an opportunity for investors to participate in the company's growth trajectory. 5. License: Drug License and GST Certificate.
7.1   Bahraich
Run Rate Sales
USD 50 thousand
EBITDA Margin
20 - 30 %
Financial Investment
USD 30 K for 20%
Contact Business

Newly Established Physiotherapy Practice Investment Opportunity in Kuta Selatan, Indonesia

Integrated wellness and recovery center in Uluwatu, Bali average fee of USD 40 per customer.
1. Location: The business is located in the sought-after area of Uluwatu, Bali. 2. Strong service offerings: The center provides a wide range of services including physiotherapy, manual therapy, massage therapy, compression therapy, IV infusions, peptides, sauna, and ice therapy, catering to a diverse clientele seeking wellness and recovery services. 3. Low competition and high barriers to entry: The industry in Bali has low competition and high barriers to entry, providing a strong market position for the business. 4. Revenue and customer base: With a steady customer base of 160-200 per day and an average spending of USD 40 per customer, we have shown strong revenue potential within just 7 months of operations. Our business expects to grow much more this year as this will be the first full calendar year for our business. 5. Qualified staff: The therapists at our center hold 4-year degrees and have an average work experience of around 2 years, ensuring high-quality service delivery. 6. Low capital requirement and high ROI: The business offers a low capital requirement and high Return on Investment (ROI) / Internal Rate of Return (IRR), making it an attractive investment.
7.6   Kuta Selatan
Run Rate Sales
USD 380 thousand
EBITDA Margin
40 %
Financial Investment
USD 220 K for 40%
Contact Business

Healthcare Services Company Investment Opportunity in Hong Kong

Business specialized in cognitive training and psychology services, 4 centres across Hong Kong. Seeking investment.
- We provide cognitive and behavioural training, counseling and assessments. - We have grown to 4 centres in Hong Kong since our creation 12 years ago, creating a niche market in a field only dominated by tutoring centres before. - We offer another way to understand and deal with learning difficulties, and parents are receptive to this. - The business model so far was only in the B2C segment. - Our newly developed digital platform complements our traditional activities but also provide us with a modern, comprehensive way to attack the B2B segment as well. - We seek investors who can enable us to reach further in the education field as well as in healthcare (cognitive and mental health/seniors) and HR (hiring / employee training and development). - Revenue is generated through charging a fee for the training program and charging a fee for the assessments. - 60%-70% of our revenue is generated through the training provided. - Currently, the business caters to 50-60 students with a training duration of an average of 9-12 months. - Currently, we have 250-280 sessions per month for assessments of individuals and families. - Our trainers and assessment providers are experienced and properly trained to provide the services. - The sales of the business will increase as we get new students. - The business was profitable before the pandemic and had to adjust since then, reducing costs and developing a digital platform that can now reach adults and seniors more easily. Currently recovering and launching new projects. - Promoter has 12 years of experience in the industry and is well-recognized by peers. Extended personal network of HK psychiatrists and psychologists.
Business specialized in cognitive training and psychology services, 4 centres across Hong Kong. Seeking investment.
9.3   Hong Kong
Run Rate Sales
USD 300 thousand
EBITDA Margin
Nil
Financial Investment
USD 320 K for 49%
Contact Business

Clinic Investment Opportunity in Bangalore, India

Well-established pharmacy, polyclinic, diagnostic center in South Bangalore with widespread B2B & B2C business.
- Polyclinic with three spacious consultation rooms, well-equipped procedure room, X-Ray, ECG. - Have a pharmacy for in-house and walk-in clients. - NABL M (EL) T accreditated laboratory run by co-founder and pathologist with 7 years of experience. - In-house state-of-the-art laboratory catering to a wide range of investigation parameters including hematology, biochemistry, cytology, clinical pathology, microbiology and histopathology. - More than 50 B2B clients in and around Bangalore with an excellent turnaround time. We collect samples from other hospitals and we conduct tests at our facility. - Full body health packages for walk-in clients. - In-house home sample collection team. - We receive 100-150 customers per day for pharmacy, 20 walk-ins for clinic and 50-100 bookings for blood tests.
8.3   Bangalore
Run Rate Sales
USD 300 thousand
EBITDA Margin
35 %
Financial Investment
USD 160 K for 25%
Contact Business

Hair Accessories Company Investment Opportunity in Mumbai, India

Providing international quality hair products and accessories for people with curly hair.
Here's a glimpse of what makes the business stand out: - Impressive Growth: Achieving INR 2.5 Cr in ARR, with 2X growth in the last year. - High Margins: Enjoying 70-75% gross margins for promising returns. The business is currently operating at a breakeven. - Strong Customer Base: Serving 100,000+ satisfied customers with a 45% retention rate. - Diverse Sales Channels: Utilizing Shopify (60%), Amazon & third-party (30%), and salon partnerships (10%). - Recognized Success: Backed by funding from Aman Gupta on Shark Tank India.
8.9   Mumbai
Run Rate Sales
USD 240 thousand
EBITDA Margin
Nil
Financial Investment
USD 120 K for 10%
Contact Business

Newly Established Yoga Studio Investment Opportunity in Singapore

Boutique yoga studio in Singapore with 80 enrolled members and curated wellness workshops.
- Boutique yoga and wellness studio in Singapore. - Studio is beautifully renovated and surrounded by nature. - We specialise in hosting curated wellness workshops, and have hosted several overseas facilitators. - We have also hosted wellness pop-ups, such as Ayurvedic massage and traditional Chinese medicine (TCM) clinics. - We have about 80 enrolled and paid members. - Attract customers through promotional offers on our website, and advertising on Google Ads, Instagram and Facebook. - We do not require any special license apart from the ACRA registration.
Boutique yoga studio in Singapore with 80 enrolled members and curated wellness workshops.
8.0   Singapore
Run Rate Sales
USD 90 thousand
EBITDA Margin
Nil
Financial Investment
USD 60 K for 50%
Contact Business

Newly Established Beauty Clinic Investment Opportunity in Dubai, United Arab Emirates

Newly opened aesthetic clinic in Business Bay, Dubai, offering advanced beauty procedures and 12 clients.
- Newly opened aesthetic clinic in Business Bay, Dubai. - The clinic offers a wide range of cutting-edge beauty procedures, including Botox and fillers, HydraFacial Syndeo, Morpheus 8, IV Drips, PRP treatments, Mesotherapy, and other advanced skin rejuvenation and wellness services, catering to a growing demand for non-invasive aesthetic treatments. - The business has faced initial challenges due to a 5-month delay in opening caused by contractor issues. The clinic has already secured 12 clients within the first 3 weeks of operation. - The average service charge per client is AED 800. - The clinic holds a trade license and DHA license, which is essential for operating in the healthcare and wellness industry in Dubai. - The clinic currently employs 4 staff members, including 1 doctor, 1 nurse, 1 beautician and a receptionist.
Newly opened aesthetic clinic in Business Bay, Dubai, offering advanced beauty procedures and 12 clients.
7.4   Dubai
Run Rate Sales
USD 33 thousand
EBITDA Margin
Nil
Financial Investment
USD 100 K for 25%
Contact Business

Hospital Investment Opportunity in New Delhi, India

Well-established 45-bed pediatric hospital in New Delhi, NABH certified with monthly revenue INR 60-70 lakhs.
- Well-established 45-bed pediatric hospital in a prime location in New Delhi. - The hospital is equipped with essential facilities including an ICU, NICU, a play area, laboratory, 24-hour pharmacy, labor room, and one operating theater. - Also offers gynecologist services and therapy sessions for mothers. - The business has obtained NABH certification. - The hospital has a dedicated team of 4 permanent doctors and 2 visiting consultants, which include pediatricians and gynaecologists. - Has an inpatient occupancy rate of 50%. - The business generates a monthly revenue ranging between INR 60-70 lakhs.
7.7   New Delhi
Run Rate Sales
USD 900 thousand
EBITDA Margin
10 - 20 %
Financial Investment
USD 450 K for 70%
Contact Business

Newly Established Gym Investment Opportunity in Denpasar, Indonesia

Seeking investment for opening a gym in Bali, offering various fitness and wellness services.
- Gym & wellness center to be started in Sanur, Denpasar, Bali, will be offering a comprehensive range of fitness and wellness services, including CrossFit, Reformer Pilates, HIIT, and Hyrox. - The center will be providing an all round holistic approach to wellness, incorporating a state-of-the-art functional fitness space, reformer Pilates studio, 25M pool (phase 2), recovery center, and an on-site physiotherapy service. As well as on-site laundry and retail shop. - The presence of a cafe on-site will provide an additional revenue stream and complements the wellness services, offering pre and post workout snacks, meals and also a fully functional cafe to service non-members. - The business owner has over 15 years of fitness and management expertise, demonstrates the ability to blend passion with business acumen, evident from the successful operation of a gym in Bali for previous investors. He has also managed high end facilities in Canada and London. This makes him a unique USP in the business, blended with his certifications, coaching over 20,000 hours of group exercise and personal training. - The owner is currently in Kuwait and will be moving back to Bali in 4 months, the business will be based completely in Bali. - Please note: The floor plan of the design for the gym is a rough guideline. 3D architect drawings are being created now.
8.0   Denpasar
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 270 K for 49%
Contact Business

Medical Supplies Company Investment Opportunity in Malé, Maldives

Pharma distribution business in Malé with consistent supplies of 50 orders/month, serving wholesalers and retailers.
- Pharma distribution business based in Malé, providing strategic access to the local pharma market and enabling efficient distribution to nearby islands. - The business has established a partnership with 1 pharma manufacturing company for the procurement of products, ensuring a consistent supply of pharmaceutical drugs. - Serves as a key supplier to wholesalers and retailers, with a significant portion of its revenue coming from wholesale supply to 2 major clients in Dhigufaru Island. - In addition to wholesale distribution, the business is involved in the distribution of multiple small pharma retailers in the same region. - Fulfills an average of 50 monthly supplies, with a monthly supply value ranging from USD 4000 to 5000, - The business is also doing cosmetics distribution to retailers on a smaller scale.
7.1   Malé
Run Rate Sales
USD 47 thousand
EBITDA Margin
40 %
Financial Investment
USD 100 K for 25%
Contact Business

Cosmetics Company Investment Opportunity in Guwahati, India

Northeast-based cosmetics brand with unique formulations seeks investment for expansion.
- Pioneer beauty products brand from the Northeast selling proprietary skincare and haircare products. - The company has its own product formulations and ingredients that it sends to its contract manufacturing unit in Jaipur. - The company's USP is its secret ingredients and formulations. - We have a small team right now, that consists of a digital marketer and salesperson. - We have a total of 7 SKUs and word of mouth is our most powerful marketing tool. - Had effective offline campaigns in 4 top colleges of Guwahati that helped us get 2 daily orders on WhatsApp. - We also have our own website and are live on marketplaces like Meesho and Amazon.
7.4   Guwahati
Run Rate Sales
USD 6 thousand
EBITDA Margin
13 %
Financial Investment
USD 12 K for 10%
Contact Business

Newly Established Generic Pharmaceuticals Company Investment Opportunity in Nashik, India

Pharma manufacturing company focusing on small volume parenterals, seeking investment for plant completion and operations.
- Pharma manufacturing company, located in Nashik. - The plant is in its final stage of commissioning and will focus on the production of small volume parenterals in ampules, vials, PFS, and lyophilized products. - Technical inspection is pending, post which the business can obtain drug manufacturing license to start the manufacturing process. - Will be manufactured on a principle-to-principle and loan license basis for both local and export markets. - The product line includes human injectable products falling under drug categories such as antibiotics, steroids, analgesics etc. - Business model involves manufacturing products under the brand and formulation of other major pharmaceutical companies and supplying them for marketing and distribution. - The business is registered with the Ministry of Corporate Affairs (MCA), holds a Permanent Account Number (PAN), and is registered with the Micro, Small, and Medium Enterprises (MSME).
7.3   Nashik
Run Rate Sales
Nil
EBITDA Margin
Nil
Financial Investment
USD 240 K for 10%
Contact Business

Frequently
Asked
Questions

  • How many healthcare business investment opportunities are listed on SMERGERS?
    There are 846 active and verified healthcare business investment opportunities listed on SMERGERS as of 29 March 2024.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more